Tharimmune appoints Vincent LoPriore to Board of Directors

Canton Strategic Holdings, Inc.

Board size increased to seven members on April 9, 2025.
Vincent LoPriore appointed as new board member effective April 9, 2025.
Tharimmune (NASDAQ: THAR) is a clinical-stage biopharmaceutical company.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Vincent LoPriore

member of the Board

CNTN · Canton Strategic Holdings, Inc.

Effective: 2025-04-09
Filed: April 10, 2025, 7:59 PM ET

appointed Vincent LoPriore as a member of the Board.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Vincent LoPriore was appointed as member of the Board at Canton Strategic Holdings, Inc..

Action: appointed
Role: member of the Board

Exact text from the filing

appointed Vincent LoPriore as a member of the Board.

View on SEC.gov

Canton Strategic Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001641172-25-003617

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.